| Advantages | They retain key disease features, including genetic mutations and protein expression profiles, making them dependable tools for cancer research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Endometrium |
| Disease | Endometrial cancer |
| Organoid Characterization | Endometrial cancer (EC) organoids display strong pathological concordance with tumor tissues, expressing key markers including vimentin (VIM), estrogen receptor (ER), and progesterone receptor (PR). |
| Applications | By preserving tumor heterogeneity and replicating critical aspects of the tumor microenvironment (TME), these models enable in-depth studies of disease progression and therapeutic response. As physiologically relevant platforms, endometrial cancer organoids are instrumental in advancing precision medicine and supporting the development of more effective treatments. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.